The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...
Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. On May 23, an Illinois jury sided with both drug manufacturers in the first ...
Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.
What are the top Barceló coupon codes for October 2024? At a glance, here are the most popular Barcelo promo codes & 2024 Summer offers. Click on one of our listed coupon codes to activate the ...
A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 ...
A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow ...
Sept 18 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer.
In Delaware, the top court is rehearing the trial court’s evidentiary ruling admitting plaintiffs’ experts’ testimony in the Zantac cases. The Third Circuit has ruled that Monsanto (Bayer) may avail ...
The superstorm is expected to inflict costly and lasting damage in Florida, as the Federal Reserve is already keeping an eye ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback